The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation
Research output: Contribution to journal › Article › peer-review
Standard Standard
The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation. / Lewis, Ruth; Bagnall, Anne-Marie; King, S. et al.
In: Health Technology Assessment, Vol. 6, No. 14, 12.2002.
In: Health Technology Assessment, Vol. 6, No. 14, 12.2002.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
Lewis, R, Bagnall, A-M, King, S, Woolacott, N, Forbes, C, Shirran, L, Duffy, S, Kleijnen, J, ter Riet, G & Riemsma, R 2002, 'The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation', Health Technology Assessment, vol. 6, no. 14. https://doi.org/10.3310/hta6140
APA
Lewis, R., Bagnall, A.-M., King, S., Woolacott, N., Forbes, C., Shirran, L., Duffy, S., Kleijnen, J., ter Riet, G., & Riemsma, R. (2002). The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation. Health Technology Assessment, 6(14). https://doi.org/10.3310/hta6140
CBE
Lewis R, Bagnall A-M, King S, Woolacott N, Forbes C, Shirran L, Duffy S, Kleijnen J, ter Riet G, Riemsma R. 2002. The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation. Health Technology Assessment. 6(14). https://doi.org/10.3310/hta6140
MLA
Lewis, Ruth et al. "The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation". Health Technology Assessment. 2002. 6(14). https://doi.org/10.3310/hta6140
VancouverVancouver
Lewis R, Bagnall AM, King S, Woolacott N, Forbes C, Shirran L et al. The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation. Health Technology Assessment. 2002 Dec;6(14). doi: 10.3310/hta6140
Author
RIS
TY - JOUR
T1 - The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer
T2 - a systematic review and economic evaluation
AU - Lewis, Ruth
AU - Bagnall, Anne-Marie
AU - King, S.
AU - Woolacott, N.
AU - Forbes, C.
AU - Shirran, L.
AU - Duffy, S.
AU - Kleijnen, J.
AU - ter Riet, G.
AU - Riemsma, R.
PY - 2002/12
Y1 - 2002/12
U2 - 10.3310/hta6140
DO - 10.3310/hta6140
M3 - Article
VL - 6
JO - Health Technology Assessment
JF - Health Technology Assessment
SN - 1366-5278
IS - 14
ER -